Nagelschmitz J[au] - Search Results

Year	Number of Results
2004	1
2008	1
2013	2
2014	2
2015	1
2016	1
2017	1
2018	1
2019	3
2020	2
2021	1
2022	3
2024	0

1

Inhaled mosliciguat (BAY 1237592): targeting pulmonary vasculature via activating apo-sGC.

Becker-Pelster EM, Hahn MG, Delbeck M, Dietz L, Hüser J, Kopf J, Kraemer T, Marquardt T, Mondritzki T, Nagelschmitz J, Nikkho SM, Pires PV, Tinel H, Weimann G, Wunder F, Sandner P, Schuhmacher J, Stasch JP, Truebel HKF. Becker-Pelster EM, et al. Among authors: nagelschmitz j. Respir Res. 2022 Oct 1;23(1):272. doi: 10.1186/s12931-022-02189-1. Respir Res. 2022. PMID: 36183104 Free PMC article.

2

Biopharmaceutical Characteristics of Nifurtimox Tablets for Age- and Body Weight-Adjusted Dosing in Patients With Chagas Disease.

Stass H, Feleder E, Garcia-Bournissen F, Nagelschmitz J, Weimann B, Yerino G, Altcheh J. Stass H, et al. Among authors: nagelschmitz j. Clin Pharmacol Drug Dev. 2021 May;10(5):542-555. doi: 10.1002/cpdd.871. Epub 2020 Oct 8. Clin Pharmacol Drug Dev. 2021. PMID: 33029953 Free PMC article. Clinical Trial.

3

Ciprofloxacin Dry Powder for Inhalation: Inspiratory Flow in Patients with Non-cystic Fibrosis Bronchiectasis.

Stass H, Nagelschmitz J, Kappeler D, Sommerer K, Patzlaff A, Weimann B. Stass H, et al. Among authors: nagelschmitz j. J Aerosol Med Pulm Drug Deliv. 2019 Jun;32(3):156-163. doi: 10.1089/jamp.2018.1464. Epub 2019 Mar 8. J Aerosol Med Pulm Drug Deliv. 2019. PMID: 30848695 Clinical Trial.

4

Results From Drug-Drug Interaction Studies In Vitro and In Vivo Investigating the Inhibitory Effect of Finerenone on the Drug Transporters BCRP, OATP1B1, and OATP1B3.

Heinig R, Fricke R, Wertz S, Nagelschmitz J, Loewen S. Heinig R, et al. Among authors: nagelschmitz j. Eur J Drug Metab Pharmacokinet. 2022 Nov;47(6):803-815. doi: 10.1007/s13318-022-00794-5. Epub 2022 Aug 27. Eur J Drug Metab Pharmacokinet. 2022. PMID: 36029368 Free PMC article.

5

Results from Drug-Drug Interaction Studies In Vitro and In Vivo Investigating the Effect of Finerenone on the Pharmacokinetics of Comedications.

Heinig R, Gerisch M, Bairlein M, Nagelschmitz J, Loewen S. Heinig R, et al. Among authors: nagelschmitz j. Eur J Drug Metab Pharmacokinet. 2020 Aug;45(4):433-444. doi: 10.1007/s13318-020-00610-y. Eur J Drug Metab Pharmacokinet. 2020. PMID: 32125665 Clinical Trial.

6

Results From Phase I Studies Investigating the Dose Linearity of Finerenone Tablets and the Influence of Food or pH-Modifying Comedications on its Pharmacokinetics in Healthy Male Volunteers.

Heinig R, Nagelschmitz J, Loewen S. Heinig R, et al. Among authors: nagelschmitz j. Eur J Drug Metab Pharmacokinet. 2022 Jul;47(4):549-559. doi: 10.1007/s13318-022-00770-z. Epub 2022 May 25. Eur J Drug Metab Pharmacokinet. 2022. PMID: 35612708

7

Safety and efficacy of the human neutrophil elastase inhibitor BAY 85-8501 for the treatment of non-cystic fibrosis bronchiectasis: A randomized controlled trial.

Watz H, Nagelschmitz J, Kirsten A, Pedersen F, van der Mey D, Schwers S, Bandel TJ, Rabe KF. Watz H, et al. Among authors: nagelschmitz j. Pulm Pharmacol Ther. 2019 Jun;56:86-93. doi: 10.1016/j.pupt.2019.03.009. Epub 2019 Mar 24. Pulm Pharmacol Ther. 2019. PMID: 30917927 Clinical Trial.

8

Pharmacokinetics of the Novel Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone (BAY 94-8862) in Individuals with Mild or Moderate Hepatic Impairment.

Heinig R, Lambelet M, Nagelschmitz J, Alatrach A, Halabi A. Heinig R, et al. Among authors: nagelschmitz j. Eur J Drug Metab Pharmacokinet. 2019 Oct;44(5):619-628. doi: 10.1007/s13318-019-00547-x. Eur J Drug Metab Pharmacokinet. 2019. PMID: 30825073

9

Inhalation of a dry powder ciprofloxacin formulation in healthy subjects: a phase I study.

Stass H, Nagelschmitz J, Willmann S, Delesen H, Gupta A, Baumann S. Stass H, et al. Among authors: nagelschmitz j. Clin Drug Investig. 2013 Jun;33(6):419-27. doi: 10.1007/s40261-013-0082-0. Clin Drug Investig. 2013. PMID: 23605507 Free PMC article. Clinical Trial.

10

Pharmacokinetics and pharmacodynamics of acetylsalicylic acid after intravenous and oral administration to healthy volunteers.

Nagelschmitz J, Blunck M, Kraetzschmar J, Ludwig M, Wensing G, Hohlfeld T. Nagelschmitz J, et al. Clin Pharmacol. 2014 Mar 19;6:51-9. doi: 10.2147/CPAA.S47895. eCollection 2014. Clin Pharmacol. 2014. PMID: 24672263 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

16 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year